A long way to go… - Director AstraZeneca Employee Review

2.0
Dec 19, 2024
Recommend
CEO approval
Business Outlook

Pros

Comprehensive portfolio, augmented through acquisitions, some positive, some poor choices. Over-ambitious profitability targets clouding good innovative science.

Cons

Extremely poor leadership. Far too much hierarchy and ineffective cascade of limited strategic thinking. Current location ‘strategy’ is senseless and huge pools of talent are being exited from the organisation. Progression is based on who likes you and critical thinking coupled with constructive criticism gets you nowhere. Walk the walk…

Explore other reviews about AstraZeneca

5.0
Jul 1, 2026
Recommend
CEO approval
Business Outlook

Pros

Robust pipeline that leads to numerous job opps

Cons

Growing quickly and rapid priority changes can be confusing

4.0
Jul 5, 2026
Recommend
CEO approval
Business Outlook

Pros

Great culture, work life balance

Cons

Costly insurance, compensation not competitive

See reviews by: Helpful|Rating|Date|All